Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Mozziconacci

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Leukemia|July 22, 2005
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocationA Murati, V Gelsi-Boyer, J Adélaïde, et al.
Oncogene|November 17, 2005
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomasB Ballester, O Ramuz, C Gisselbrecht, et al.
Blood|August 15, 2000
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangementsD Sainty, V Liso, A Cantù-Rajnoldi, et al.
European Journal of Haematology|November 30, 2023
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patientsC Petit, C Saillard, B Mohty, et al.
Blood Cancer Journal|June 4, 2020
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility studyA Collignon, M A Hospital, C Montersino, et al.
Leukemia|August 29, 2015
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemiaI Antony-Debré, N Duployez, M Bucci, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Cancer Genetics and Cytogenetics|December 13, 2005
Cytogenetic study of 75 erythroleukemiasM Lessard, S Struski, V Leymarie, et al.
Cancer Genetics and Cytogenetics|June 19, 2007
Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?M Lessard, C Hélias, S Struski, et al.
Leukemia|June 6, 2008
Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologiqueC Gervais, A Murati, C Helias, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Leukemia|July 22, 2005
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocationA Murati, V Gelsi-Boyer, J Adélaïde, et al.
Oncogene|November 17, 2005
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomasB Ballester, O Ramuz, C Gisselbrecht, et al.
Blood|August 15, 2000
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangementsD Sainty, V Liso, A Cantù-Rajnoldi, et al.
European Journal of Haematology|November 30, 2023
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patientsC Petit, C Saillard, B Mohty, et al.
Blood Cancer Journal|June 4, 2020
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility studyA Collignon, M A Hospital, C Montersino, et al.
Leukemia|August 29, 2015
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemiaI Antony-Debré, N Duployez, M Bucci, et al.
Blood|August 15, 2000
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies"D Grimwade, A Biondi, M J Mozziconacci, et al.
Cancer Genetics and Cytogenetics|December 13, 2005
Cytogenetic study of 75 erythroleukemiasM Lessard, S Struski, V Leymarie, et al.
Cancer Genetics and Cytogenetics|June 19, 2007
Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?M Lessard, C Hélias, S Struski, et al.
Leukemia|June 6, 2008
Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologiqueC Gervais, A Murati, C Helias, et al.
Pageof 7